- Home
- SFHG vs BOLT Comparison
SFHG vs BOLT Comparison
Compare SFHG & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SFHG
- BOLT
- Stock Information
- Founded
- SFHG 1993
- BOLT 2015
- Country
- SFHG Hong Kong
- BOLT United States
- Employees
- SFHG N/A
- BOLT N/A
- Industry
- SFHG Publishing
- BOLT Biotechnology: Pharmaceutical Preparations
- Sector
- SFHG Consumer Discretionary
- BOLT Health Care
- Exchange
- SFHG Nasdaq
- BOLT Nasdaq
- Market Cap
- SFHG 11.7M
- BOLT 11.5M
- IPO Year
- SFHG 2024
- BOLT 2021
- Fundamental
- Price
- SFHG $0.50
- BOLT $5.60
- Analyst Decision
- SFHG
- BOLT Buy
- Analyst Count
- SFHG 0
- BOLT 4
- Target Price
- SFHG N/A
- BOLT $34.00
- AVG Volume (30 Days)
- SFHG 54.2K
- BOLT 26.4K
- Earning Date
- SFHG 10-30-2025
- BOLT 11-14-2025
- Dividend Yield
- SFHG N/A
- BOLT N/A
- EPS Growth
- SFHG N/A
- BOLT N/A
- EPS
- SFHG N/A
- BOLT N/A
- Revenue
- SFHG $19,577,200.00
- BOLT $4,167,000.00
- Revenue This Year
- SFHG N/A
- BOLT N/A
- Revenue Next Year
- SFHG N/A
- BOLT N/A
- P/E Ratio
- SFHG N/A
- BOLT N/A
- Revenue Growth
- SFHG 3.56
- BOLT N/A
- 52 Week Low
- SFHG $0.55
- BOLT $4.59
- 52 Week High
- SFHG $24.00
- BOLT $13.80
- Technical
- Relative Strength Index (RSI)
- SFHG 21.04
- BOLT 47.49
- Support Level
- SFHG $0.58
- BOLT $5.65
- Resistance Level
- SFHG $0.68
- BOLT $5.93
- Average True Range (ATR)
- SFHG 0.03
- BOLT 0.32
- MACD
- SFHG -0.00
- BOLT -0.05
- Stochastic Oscillator
- SFHG 2.49
- BOLT 9.31
About SFHG Samfine Creation Holdings Group Limited Ordinary Share
Samfine Creation Holdings Group Ltd operates through its subsidiaries. It is an established one-stop printing service provider which principally provides printing services in Hong Kong and the PRC. It offers a wide range of printed products such as (i) book products, which mainly include children's books, educational books, art books, notebooks, diaries and journals; and (ii) novelty and packaging products, which mainly include handcraft products, book sets, pop-up books, stationery products, products with assembly parts and other specialized products, shopping bags and package boxes.
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.